Koers True Leaf Medicine International Ltd Other OTC
Aandelen
CA89785C1077
Farmaceutische producten
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 4,2 mln. 3,07 mln. 2,86 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -6 mln. -4,39 mln. -4,08 mln. | Nettowinst (verlies) 2022 | -2 mln. -1,46 mln. -1,36 mln. | EV/omzet 2021 | - |
Nettoschuld 2021 | 4,22 mln. 3,08 mln. 2,87 mln. | Nettoschuld 2022 | 5,91 mln. 4,32 mln. 4,02 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-1,36
x | K/w-verhouding 2022 |
-1,66
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 88,37% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Darcy E. Bomford
FOU | Founder | - | 01-01-13 |
Jennifer Pace
DFI | Director of Finance/CFO | - | 01-04-20 |
Rik Klingle-Watt
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mike Harcourt
CHM | Chairman | - | 09-06-14 |
Jennifer Pace
DFI | Director of Finance/CFO | - | 01-04-20 |
Darcy E. Bomford
FOU | Founder | - | 01-01-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+27,29% | 5,63 mld. | |
-33,07% | 3,57 mld. | |
-3,24% | 3,08 mld. | |
-24,56% | 2,65 mld. | |
-10,17% | 2,29 mld. | |
+46,81% | 1,99 mld. | |
+48,03% | 1,54 mld. | |
-11,69% | 1,45 mld. | |
+43,81% | 1,39 mld. |